Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
solifenacin succinate, Quantity: 5 mg
Arrotex Pharmaceuticals Pty Ltd
Solifenacin succinate
Tablet, film coated
Excipient Ingredients: polyvinyl alcohol; croscarmellose sodium; purified talc; titanium dioxide; iron oxide yellow; magnesium stearate; macrogol 8000; lactose; hyprolose
Oral
30
(S4) Prescription Only Medicine
Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.
Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2016-01-12